Adipocytokines: Potential biomarkers for childhood obesity and anorexia nervosa?;Adipocitochine: Potenziali biomarker di obesità e anoressia nervosa in età pediatrica?

Minerva Pediatrica

Volumn 62, Issue 2, 2010, Pages 171-178

  Leoni, M C ^a   Pizzo, D ^a   Marchi, A ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Adipokines; Adipose tissue; Anorexia nervosa; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GHRELIN; LEPTIN; RESISTIN;

ANOREXIA NERVOSA; BODY FAT; BODY WEIGHT; CHILD; CHILDHOOD; CORRELATION ANALYSIS; DISEASE MARKER; ENERGY EXPENDITURE; FOOD INTAKE; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; NUTRITIONAL STATUS; OBESITY; PATHOPHYSIOLOGY; REVIEW;

ADIPOKINES; ADOLESCENT; ANOREXIA NERVOSA; BIOLOGICAL MARKERS; CHILD; HUMANS; OBESITY;

EID: 77954712946     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. Transcriptional regulation of adipogenesis. Genes Dev 2000;14:1293-307.
2. Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond B Biol Sci 1953;140:578-96.
3. Lee DE, Kehlenbrink S, Lee H, Hawkins MA, Yudkin JS. Getting the message across-mechanisms of physiological cross-talk by adipose tissue. Am J Physiol Endocrinol Metab 2009 [Epub ahead of print].
4. Lionetti L, Mollica MP, Lombardi A, Cavaliere G, Gifuni G, Barletta A. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation. Nutr Metab Cardiovasc Dis 2009;19:146-52.
5. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am. J. Physiol. Heart Circ Physiol 2005;288:2031-41.
6. Guzik TJ, Mangalat D, Korbut R. Adipocytokines-novel link between inflammation and vascular function? J Physiol Pharmacol 2006;57:505-21.
7. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Publishing Group 2006;6:772-83.
8. Eyzaguirre F, Mericq V. Insulin resistance markers in children. Horm Res 2009;71:65-74.
9. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulatin in adipose tissue. J Clin Invest 2003;112:1796-808.
10. Wellen K, Gökhan SH. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003;112:1785-8.
11. Yoshinaga M, Sameshima K, Tanaka Y, Wada A, Hashiguchi J, Tahara H et al. Adipokines and the prediction of the accumulation of cardiovascular risk factors or the presence of metabolic syndrome in elementary school children. Circ J 2008;72:1874-8.
12. Madeira IR, Carvalho CN, Gazolla FM, Pinto LW, Borges MA, Bordallo MA. Impact of obesity on metabolic syndrome components and adipokines in prepubertal children. J Pediatr (Rio J) 2008;85(2).
13. Weiss R, Dziura J, Burget TS, Tamborlane WV, Taksali SE, Yeckel CW et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-74.
14. Winer JC, Zern TL, Taksali SE, Dziura J, Calo AMG, Wollschlager M et al. Adiponectin in childhood and adolescent obasity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab 2006;91:4415-23.
15. Cambuli VM, Musiu MC, Incani M, Paderi M, Serpe R, Marras V et al. Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children J Clin Endocrinol Metab 2008;93:3051-7.
16. De Luis DA, Perez Castrillon JL, Duenas A. Leptin and obesity. Minerva Med 2009 [Epub ahead of print].
17. Oral EA. Lipoatrophic diabetes and other related syndromes. Rev Endocr MetabDisord 2003;4:61-77.
18. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI et al. Abnormal splicing of the leptin receptor in diabetics mice. Nature 1996;379:632-5.
19. Dubey S, Kabra M, Bajpai A, Pandey RM, Hasan M, Gautam RK et al. Serum leptin levels in obese indian children: relation to clinical and biochemical parameters. Indian Pediatrics 2007;44:257-62.
20. Münzberg H, Björnholm M, Bates SH, Myers MG Jr. Leptin receptor action and mechanisms of leptin resistance. Cell Mol Life Sci 2005;62:642-52.
21. Blüher S, Mantzoros CS. Leptin in humans: lessons from translational research. Am J Clin Nutr 2009;89:991S-7S.
22. Murphy MJ, Hosking J, Metcalf BS, Voss LD, Jeffery AN, Sattar N et al. Distribution of adiponectin, leptin, and metabolic correlates of insulin resistance: a longitudinal study in British children; 1: Prepuberty (EarlyBird 15) Clin Chem 2008;54:1298-306.
23. Shea SA, Hilton MF, Orlova C, Ayers RT, Mantzoros CS. Independent circadian and sleep/wake regulation of adipokines and glucose in humans. J Clin Endocrinol Metab 2005;90:2537-44.
24. La Cava A, Alviggi C, Matarese G. Unravelling the multiple roles of leptin in inflammation and autoimmunity. Int J Molec Med 2004;82:4-11.
25. Yoshinaga M, Sameshima K, Tanaka Y, Wada A, Hashiguchi J, Tahara H et al. Adipokines and the prediction of the accumulation of cardiovascular risk factors or the presence of metabolic syndrome in elementary school children. Circ J 2008;72:1874-8.
26. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H et al. Recent advances in the relationship between obesity, inflammation and insulin-resistance. Eur Cytochine Netw 2006;17:4-12.
27. Sacheck J. Pediatric obesity: an inflammatory condition? Jpen J Parenter Enteral Nutr 2008:32:633-7.
28. Farooqi IS, O'Rahilly S. Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr 2009;89:980S-4S.
29. Hebebrand J, Muller TD, Holtkamp K, Herpertz-Dahlmann B. The role of leptin in anorexia nervosa: clinical implications. Mol Psychiatry 2007;12:23-35.
30. Blüher S, Mantzoros CS. Leptin in humans: lessons from translational research. Am J Clin Nutr 2009;89:991S-7S.
31. Chan JL, Mantzoros CS. Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 2005;366:74-85.
32. Riccioni G, D'Orazio N, Menna V, Lambo MS, Guagnano MT, Di Ilio C. Role of leptin in anorexia nervosa. Clin Ter 2003;154:401-4.
33. Mantzoros C, Flier JS, Lesem MD, Brewerton TD, Jimerson DC. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. J Clin Endocrinol Metab 1997;82:1845-51.
34. Krizova J, Papezova H, Haluzikova D, Parizkova J, Jiskra J, Kotrlikova E et al. Soluble leptin receptor levels in patients with anorexia nervosa. Endocr Res 2002;28:199-205.
35. Modan-Moses D, Stein D, Pariente C, Yaroslavsky A, Ram A, Faigin M et al. Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. J Clin Endocrinol Metab 2007;92:1843-7.
36. Baranowska B, Baranowska-Bik A, Bik W, Martynska L. The role of leptin and orexins in the dysfunction of hypothalamo-pituitary-gonadal regulation and in the mechanism of hyperactivity in patients with anorexia nervosa. Neuro Endocrinol Lett 2008;29:37-40.
37. Jayasinghe Y, Grover SR, Zacharin M. Current concepts in bone and reproductive health in adolescents with anorexia nervosa. BJOG 2008;115:304-15.
38. Misra M, Klibanski A. Anorexia nervosa and osteoporosis. Rev Endocr Metab Disord 2006;7:91-9.
39. Mehler PS. Osteoporosis in anorexia nervosa: prevention and treatment. Int J Eat Disord 2003;33:113-26.
40. Madeira IR, Carvalho CN, Gazolla FM, Pinto LW, Borges MA, Bordallo MA. Impact of obesity on metabolic syndrome components and adipokines in prepubertal children J Pediatr (Rio J) 2008;85(2).
41. Yoo EG, Kim DH. Determinants of plasma adiponectin levels in obese children. J Pediatr Endocrinol Metab 2008;21:737-43.
42. Panagopoulou P, Galli-Tsinopoulou A, Fleva A, Pavlitou-Tsiontsi E, Vavatsi-Christaki N, Nousia-Arvanitakis S. Adiponectin and insulin resistance in childhood obesity. J Pediatr Gastroenterol Nutr 2008;47:356-62.
43. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002;277:25863-6.
44. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003;14:561-6.
45. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K et al. Cloning of adiponectina receptors that mediate antiduabetic metabolic effects. Nature 2003;423:762-9.
46. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-83.
47. Jeffery AN, Murphy MJ, Metcalf BS, Hosking J, Voss LD, English P et al. Adiponectin in childhood. Int J Pediatr Obes 2008;3:130-40.
48. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002;277:37487-91.
49. Sabin MA, Holly JM, Shield JP, Turner SJ, Grohmann MJ, Stewart CE et al. Mature Subcutaneous and visceral adipocyte concentrations of adiponectina are highly correlated in prepubertal children and inversely related to body mass index standard deviatin score. J Clin Endocrinol Metab 2006;91:332-5.
50. Delporte ML, Brichard SM, Hermans MP, Beguin C, Lambert M. Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) 2003;58:22-9.
51. Dostálová I, Smitka K, Papezová H, Kvasnicková H, Nedvídková J. Increased insulin sensitivity in patients with anorexia nervosa: the role of adipocytokines. Physiol Res 2007;56:587-94.
52. Bosy-Westphal A, Brabant G, Haas V, Onur S, Paul T, Nutzinger D et al. Determinants of plasma adiponectin levels in patients with anorexia nervosa examined before and after weight gain. Eur J Nutr 2005;44:355-9.
53. Brichard SM, Delporte ML, Lambert M. Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm Metab Res 2003;35:337-42.
54. Dostalova I, Kunesova M, Duskova J, Papezova H, Nedvidkova J. Adipose tissue resistin levels in patients with anorexia nervosa. Nutrition 2006;22:977-83.
55. Vendrell J, Broch M, Vilarrasa N, Molina A, Gómez JM, Gutiérrez C et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obesity Research 2004;12:962-9.
56. Silha J, Krsek M, Skrha J, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003;149:331-5.
57. Koerner A, Kratzsch J, Kiess W. Adipocytokines: leptin-the classical, resistin-the controversical, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005;19:525-46.
58. Fukahara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K. Visfatin: a protein secreted by visceral fat than mimics the effect of insulin. Science 2005;307:426-30.
59. Dostálová I, Sedláãková D, PapeÏová , Nedvídková J, Haluzík M. Serum visfatin levels in patients with anorexia nervosa and bulimia nervosa. Physiol Res 2009;58:903-7.
60. Brescianini S, Gargiulo L, Gianicolo E, editors. Informazione statistica e politiche per la promozione della salute. Proceedings of the ISTAT Congress; 2002 September 10-12 Rome, Italy. Rome: CSR; 2004.
61. Research Laboratories Merck. The Merck Manual. V edizione. Milano: Springer-Verlag; 2008.
62. Faravelli C, Ravaldi C, Truglia E, Zucchi T, Cosci F, Ricca V. Clinical epidemiology of eating disorders: results from the Sesto Fiorentino Study. Psychother Psychosom 2006;75:376-83.
63. Venner AA, Lyon ME, Doyle-Baker PK. Leptin: a potential biomarker for childhood obesity? Clin Biochem 2006;39:1047-56.